Author: BioactiveCompoundLibrary

Similar to human measles clinical findings in canine distemper virus -infected dogs include fever, rash, respiratory signs, and lymphopenia. Affected animals are prone to opportunistic infections as a consequence of generalized lymphoid depletion and profound immunosuppression. Moreover, persistent infection of peripheral lymphoid organs and the central nervous system of carnivores leads to long lasting immune alterations and immune mediated neuropathology. Dendritic cells represent the most potent antigen presenting cell population, which initiate primary T cell responses and play an important role also for B cell immunity. Several pathogens, including human herpesvirus type-1 as well as human and feline immunodeficiency viruses, target DCs and have evolved strategies to modulate their cytokine expression and antigen presenting capacity, thereby promoting virus immune evasion and persistence. Other mechanisms include alteration of endocytosis, vesicle trafficking, and immunological synapse formation or apoptosis induction of infected DCs. A disturbed function of antigen presenting cells, including DCs, is supposed to contribute to immunosuppression in measles patients. Moreover, following infection of the respiratory tract, MV-infected DCs might mediate virus transmission to secondary lymphoid organs. During the chronic disease stage of canine distemper, cells with a DC-like morphology seem to serve as the primary host cells for the virus, which might promote viral persistence in lymphoid organs. Thus, an inhibited terminal differentiation of DCs is currently discussed to be responsible for diminished antigen presenting function and disturbed repopulation of lymphoid tissues in CDV-infected dogs, as suggested for MV-infection. In addition, CDV-infection of thymic DCs may result in compromised T cell maturation, promoting the release of immature, potentially autoreactive lymphocytes, demonstrating a potential participation of DCs in both CDV-induced immunosuppression and immunopathology. However, whether CDV has the ability to infect canine DCs and direct viral effects upon these professional antigen presenting cells have not yet been confirmed. The aim of the present study was to determine the permissiveness of canine DCs to CDV in vitro. Besides antigen presentation via the major histocompatibility complex, adequate T cell activation by DCs requires co-stimulation by molecules such as CD80 and CD86. An additional signal is mediated by DC-released cytokines leading to T cell polarization. Thus, in order to testify the hypothesis that infection leads to an impaired T cell stimulatory capacity of these cells, the impact of CDV upon molecules involved in antigen presentation and co-stimulation and the associated cytokine expression was investigated. The present study demonstrates the ability of CDV to infect canine DCs and to modulate their antigen presenting properties and cytokine expression.

lt brain compared to 20% and 100% for newborn and AD brain respectively, indicating that adult tau protein is not extensively phosphorylated. Furthermore, developmental studies in rodents have shown that while some epitopes, such as pT205 or pT181, are highly phosphorylated in the post-embryonic brain, their signal is very faint in adult brain, which could explain why AT8 and AT270 are more prone to display non-specific Igs signal. On the other hand, epitopes such as pS202 or pS396 and pS404 are abundant in the adult brain, and do not display overt non-specific signal in our experiments. We were surprised to see a non-specific signal around 37 kD with the MC1 antibody in Tau KO mice. This antibody recognizes an abnormal conformation of tau encompassing amino acids 5–15 and 312–322. We think that this non-specific signal is due to the knock-in of the EGFP coding sequence into the first exon disrupting the expression of the Mapt gene, and resulting in a chimeric protein with EGFP fused to the first 31 amino acids of tau. Indeed, the same band was detected with an anti-GFP antibody and disappeared in the HS fraction. These results indicate that, somehow, the fusion of EGFP to the small sequence of tau was able to mimic the MC1 epitope. To help improve the detection of tau signal, we first used secondary antibodies designed to bind native Igs. Because Igs coming from the samples are denatured, these antibodies recognize only the primary antibodies, and eliminate the interference of Igs heavy and light chains during the Western blot procedure. Indeed, TrueBlot antibodies completely removed the non-specific signal from problematic primary antibodies in TKO, WT and 3xTg mice, allowing for the visualization of tau signal without interference. The use of TrueBlot antibodies did not necessitate an important modification of the standard Western blot procedure as they replaced conventional secondary antibodies. However, we observed that it was sometimes difficult to obtain a signal with TrueBlot secondary antibodies; hence, we had to increase the amount of protein being loaded or alter their incubation time from 1 h at room temperature for standard secondary antibodies to overnight or more at 4uC with TrueBlot. As an alternative to TrueBlot, we also tested secondary antibodies designed to bind the light chain of Igs at 25 kDa and do not recognize the heavy chain at 50 kDa. These antibodies recognize only the primary antibodies and the light chain of Igs on the membrane, and eliminate the interference of Igs heavy chains in Western blot procedure. Indeed, anti-LC antibodies completely removed the non-specific signal from problematic primary antibodies in TKO, WT and 3xTg mice, allowing a visualization of tau signal without interference. Furthermore, the use of LC antibodies has several advantages versus TrueBlot antibodies: they are less expensive, can be diluted more, and incubated at room temperature for 1 h.

Subsequent studies have revealed putative PIP2-interacting domains in the polybasic proximal C-terminal region of TRPV1. In addition, polyunsaturated fatty acids, their metabolites and lysophosphatidic acid are also known to modulate TRPV1channel function. Interestingly, intracellular levels of the anionic long chain acyl CoA esters are increased in many pathophysiological conditions including those mentioned above, resulting in alterations of metabolic enzyme activity, gene transcription and the immune mediated inflammatory response. Similar to PIP2, LC-CoAs are comprised of a hydrophobic tail with a negatively charged head group. Our group and others have shown that LC-CoAs have a direct and potent stimulatory effect on the ATP-sensitive potassium channel and that PIP2 and LC-CoAs possess a similar molecular mechanism of action via interaction with intracellular positively charged basic regions of the KATP channel. Additional work in our laboratory also shows that LC-acyl CoAs and PIP2 modulate the sodium-calcium exchanger via interaction with common basic residues. Therefore, in this current study we investigated whether LCCoAs, like PIP2, regulate TRPV1 activity by characterizing the effects of physiological intracellular concentrations of common dietary LC-CoAs on recombinant TRPV1 channel activity. We also determined the effects of intracellular LC-CoA elevation on TRPV1 channel-mediated intracellular Ca2+ accumulation in intact cell models. Finally, we investigated the role of known PIP2 interacting amino acid residues in the TRPV1 channel to elucidate the molecular interactions responsible for LC-CoA modulation of TRPV1 channel function. Our results demonstrate that sub-micromolar physiological levels LC-CoAs are potent positive modulators of TRPV1 channel activity and act via a similar, but not identical, molecular mechanism to PIP2. Though the precise molecular mechanisms may differ, it is well known that PIP2 regulates the function of many trans-membrane ion transport proteins. Early studies stated that PIP2 had a tonic inhibitory effect on TRPV1 channel function proposing that this inhibition was relieved by nerve growth factor via activation of its tyrosine kinase receptor and effector PLC, resulting in PIP2 cleavage. Further investigation found that NGF actually led to an increase in the amount of TRPV1 channels present at the membrane, questioning the theory of PIP2 TRPV1 inhibition. Though some controversy still exists it is now generally accepted that depletion of PIP2 from the plasma membrane leads to inactivation of TRPV1 channels, suggesting that PIP2 is both a positive modulator of TRPV1 and a requirement for channel function. Our current data show that TRPV1 is positively modulated by LC-CoAs. Indeed, previous work in our laboratory has shown that LC-CoAs modulate KATP channels and NCX1 in a similar manner to PIP2.

Thus, stathmin is expressed higher in DPSCs than in CDPSCs. The essential role of stathmin in regulating the cytoskeleton microtubules indicated that it may be required for the biological functions of DPSCs. Another group of differentially expressed proteins is correlated with cell cytoskeleton and motility and includes TPM2, MYL9, CAPZB, CAPG, KRT9 and KRT10. Tropomyosins are a family of actin-filament binding proteins expressed in most eukaryotic cells. In human, there are at least four TPM genes. TPM2 is found primarily in skeletal muscles and this protein helps regulate muscle contraction by interacting with other muscle proteins, particularly myosin and actin. In addition, TPM2 is essential for cytoskeleton establishment and the regulation of TGF-b induced stress fiber formation. MYL9 can be phosphorylated by myosin light chain kinase in the presence of calcium and calmodulin. This phosphorylation contributes to the increase in the actin-activated ATPase activities of myosins. MYL9 is involved in the regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Moreover, phosphorylation of MYL9 alters myocardium contraction by increasing the force and rate of force development. CAPZB is a heterodimer with an a subunit of 32-36 kDa and a b subunit of 28-32 kDa. The actin barbed end capping protein is highly conserved and found in nearly all eukaryotic cells. CAPZB regulates the assembly of actin filament structures which are required for numerous biological processes and precise coordination. CAPG is a member of the gelsolin-villin family, and it binds to actin in a calcium-dependent manner. CAPG is wildly distributed in tissues and cells. Previous studies have shown that its function is closely correlated with the motility and ruffling of various cell types including macrophages, neutrophils, fibroblasts, and endothelial cells,. Recently, CAPG was reported to be an essential protein for the embedding and dendrite elongation processes in osteocytes. KRT9, a type I intermediate filament protein, is abundant in human foot soles and palms. In mice, KRT9 is a major component of the perinuclear ring of manchette in spermatids and is required for normal sperm development. Mutation of KRT9 is responsible for human epidermolytic palmoplantar keratoderma and degenerative changes of keratin’s intermediate filament structure. KRT10, a type I keratin protein, is normally expressed in the suprabasal epidermal compartment. Deletion of KRT10 impairs permeability barrier function and stratum corneum hydration. KRT10 is required for epidermal integrity, as KRT10 mutation leads to epidermolytic hyperkeratosis. In this study, 3 identified proteins were mainly related to antioxidative function including TALDO1, GLRX3, and APEH. TALDO1 is an enzyme of the pentose phosphate pathway.

Both proteins had been shown to be deregulated in other cancers in a manner that was associated with tumour progression. Recently we reported an association of Microcephalin and ASPM levels in malignant cells derived from ascitic fluids from EOC patients with various clinic-pathological parameters. In the present, larger scale study, nuclear and/or cytoplasmic Microcephalin staining was identified in the tumour cells. Our results in the training set revealed a reduction in nuclear Microcephalin expression in 73% of EOC tumours; this percentage was reduced to 30% in the validation set. This difference between the two cohorts potentially reflects the higher number of grade 3 cases in the training set compared to the validation set. In this study low Microcephalin expression was identified in high grade and advanced stage tumours. These findings match our previous study on ovarian ascites samples that indicated that Microcephalin expression was reduced in cell cultures derived from ascites of EOC patients with advanced tumours. Our results are compatible with studies that reporting reduced MCPH1 DNA copy number in 72% of breast cancers and to our own findings of reduced Microcephalin expression in 93/319 of breast cancer samples, particularly in the higher grade tumours. Previously, we identified a correlation between the abnormal localization of Microcephalin with tumour grade in primary cultures of malignant cells derived from ascitic fluids from patients with EOC. In these cells, cytoplasmic Microcephalin increased with tumour grade. We suggested that might be because of MCPH1 deletion mutations in the C-terminal BRCT domains that have previously been shown to result in Microcephalin moving from a nuclear to cytoplasmic localization similar to BRCA1. A recent study characterizing different MCPH1 splice variants reported mutation or deletion of nuclear localization signals within the MCPH1 gene resulted in a localization change from nuclear to cytoplasmic. In this study weak to moderate Microcephalin cytoplasmic staining was seen in all grade 2 and 3 samples and increased cytoplasmic Microcephalin expression was associated with increased tumour grade. However due to non-specific background cytoplasmic staining observed in the blocking peptide experiment, cytoplasmic expression was not included here. Our findings of reduced expression of the DNA repair protein Microcephalin in high grade tumours but few low grade tumours is consistent with the molecular characteristics of these different tumour types. Loss of DNA repair function e.g. BRCA genes leading to chromosomal instability and a complex genome is common in high grade cancers. In contrast to low grade tumours which do not tend to display chromosomal instability and BRCA mutations. Similarly to Microcephalin expression, in this study we recapitulated our recent findings on cytoplasmic ASPM levels and tumour grade. In primary cultures of malignant cells derived.